Login / Signup

Double-blind, randomized, 8-week multicenter study of the efficacy and safety of STW 5-II versus placebo in functional dyspepsia.

Bettina VinsonCareen FinkManfred WargenauNicholas J TalleyGerald J Holtmann
Published in: JGH open : an open access journal of gastroenterology and hepatology (2024)
STW 5-II is efficacious, with no observed safety signals at up to 8 weeks of treatment in patients with FD meeting Rome II or IV criteria.
Keyphrases
  • double blind
  • placebo controlled
  • phase iii
  • clinical trial
  • phase ii
  • open label
  • study protocol
  • combination therapy
  • irritable bowel syndrome